MERSANA THERAPEUTICS INC's ticker is MRSN and the CUSIP is 59045L106. A total of 124 filers reported holding MERSANA THERAPEUTICS INC in Q4 2021. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $55,411 | -70.3% | 43,631 | -23.1% | 0.00% | – |
| Q2 2023 | $186,566 | -91.0% | 56,707 | -88.7% | 0.00% | -100.0% |
| Q1 2023 | $2,063,872 | +22.8% | 502,159 | +75.0% | 0.00% | +50.0% |
| Q4 2022 | $1,681,198 | +3.9% | 286,894 | +19.9% | 0.00% | 0.0% |
| Q3 2022 | $1,617,560 | +957.2% | 239,284 | +621.3% | 0.00% | – |
| Q2 2022 | $153,000 | +45.7% | 33,172 | +26.0% | 0.00% | – |
| Q1 2022 | $105,000 | -36.0% | 26,326 | 0.0% | 0.00% | – |
| Q4 2021 | $164,000 | -34.1% | 26,326 | -0.4% | 0.00% | – |
| Q3 2021 | $249,000 | -30.6% | 26,438 | 0.0% | 0.00% | -100.0% |
| Q2 2021 | $359,000 | -3.2% | 26,438 | +15.2% | 0.00% | 0.0% |
| Q1 2021 | $371,000 | -39.6% | 22,950 | -0.5% | 0.00% | 0.0% |
| Q4 2020 | $614,000 | +83.8% | 23,060 | +28.5% | 0.00% | 0.0% |
| Q3 2020 | $334,000 | -10.2% | 17,939 | +12.7% | 0.00% | 0.0% |
| Q2 2020 | $372,000 | +235.1% | 15,916 | -16.1% | 0.00% | – |
| Q1 2020 | $111,000 | +1.8% | 18,967 | 0.0% | 0.00% | – |
| Q4 2019 | $109,000 | +419.0% | 18,967 | +45.1% | 0.00% | – |
| Q3 2019 | $21,000 | -60.4% | 13,069 | 0.0% | 0.00% | – |
| Q2 2019 | $53,000 | – | 13,069 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Ally Bridge Group (NY) LLC | 1,191,271 | $6,980,848 | 6.79% |
| Bain Capital Life Sciences Investors, LLC | 8,663,673 | $50,769 | 5.67% |
| ACUTA CAPITAL PARTNERS, LLC | 950,000 | $5,567,000 | 3.43% |
| Sarissa Capital Management LP | 3,997,010 | $23,422,479 | 2.79% |
| Decheng Capital Management III (Cayman), LLC | 904,268 | $5,299,010 | 1.98% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 1,140,182 | $6,681,467 | 1.91% |
| Orbimed Advisors | 9,011,437 | $52,807,021 | 1.01% |
| Opaleye Management Inc. | 460,000 | $2,695,600 | 0.94% |
| Artal Group S.A. | 2,200,000 | $12,892 | 0.72% |
| DAFNA Capital Management LLC | 413,463 | $2,422,893 | 0.68% |